Lipocine Inc. Leases Disclosure
| (8) | Leases |
The Company has a non-cancelable operating lease for office space and laboratory facilities in Salt Lake City, Utah. On December 8, 2025, the term of the lease was extended through February 28, 2027.
Future minimum lease payments under the non-cancelable operating lease as of December 31, 2025 are:
| Operating | ||||
| Lease | ||||
| Year ending December 31: | ||||
| 2026 | $ | 385,139 | ||
| 2027 | 64,452 | |||
| Total minimum lease payments | $ | 449,591 | ||
The Company’s rent expense was $376,000 and $366,000 for the years ended December 31, 2025 and 2024, respectively.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 10, 2026 | Showing above |
| 2024 | Mar 13, 2025 | |
| 2023 | Mar 7, 2024 | |
| 2022 | Mar 10, 2023 | |
| 2021 | Mar 9, 2022 | |
| 2020 | Mar 11, 2021 | |
| 2019 | Mar 13, 2020 | |
| 2018 | Mar 6, 2019 | |
| 2017 | Mar 12, 2018 | |
| 2016 | Mar 6, 2017 | |
| 2015 | Mar 10, 2016 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.